Uterine Corpus Sarcoma — Trials

Uterine Corpus Sarcoma — Trials · CancerIndex

Clinical trials

Registered studies

359 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 46
Recruiting: 22
Ph III recruiting: 4
Growth YoY: —
Industry share: 15%
Top sponsor: Assistance Publique Hopitaux De Marseille
Termination share: 24.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (52)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02942537	Study of Volume Reduction of Uterine Fibroids After Embolization or Microwave Treatment(MYOMIC1)	unknown	Phase 2 / Phase 3	36	Karolinska InstitutetOTHER	1	Oct 2, 2018	clinicaltrials
NCT03550703	Open Label Immunotherapy of Myoma(V3-myoma)	unknown	Phase 2	30	Immunitor LLCINDUSTRY	1	Jul 6, 2018	clinicaltrials